CITIGROUP INC. (C)
Upgrading — Outperform

Adjusted Returns Hit 9.7%, Every Business Sets a Record, the Banamex Exit Path Is Secured — Upgrading Citigroup to Outperform

Published: By A.N. Burrows C | Q3 2025 Earnings Recap
Independence Disclosure. Aardvark Labs Capital Research does not hold a position in Citigroup Inc., has no investment banking relationship with Citigroup, and was not compensated by C or any affiliated party for this report. Views are our own and may differ materially from sell-side consensus.

Key Takeaways

  • A high-quality beat with a clean operating story under a noisy GAAP headline: adjusted EPS of $2.24 beat the ~$1.94 Street by ~$0.30 (reported EPS $1.86 absorbed a $726M, capital-neutral Banamex goodwill impairment), revenue grew 9% to $22.1B with every one of the five businesses setting a record third quarter, and the firm again posted positive operating leverage everywhere. The stock rose 3.9% to $99.84, crossing above tangible book value for the first time this cycle.
  • The returns are now at the doorstep of the target. Adjusted RoTCE reached 9.7% in the quarter (9.2% year-to-date) — within a hair of the 10-11% 2026 goal Fraser still calls a “waypoint.” The internal mix improved across the board: Services 28.9%, Banking 12.3% (up from 9%), USPB 14.5% (up from 11%), Markets 12.3%, Wealth 12.1%. The dispersion we flagged at Q2 as the gating issue is narrowing.
  • The two biggest overhangs took concrete steps toward resolution. (1) Banamex: an agreement with Fernando Chico Pardo to buy a 25% stake at 0.8x book secures the path to deconsolidation and full exit (RWA ~$37B to be released), with his regulatory filing already in. (2) Transformation: over two-thirds of programs are at or near target state, controls are now “in line with peers” on automation, and management confirmed 2025 transformation spend at <$3.5B with a 2026 step-down. These are precisely the upgrade triggers we set at initiation.
  • Capital return accelerated: $6B+ returned to common ($5B of buybacks, $1B above guide; $8.75B YTD of the $20B program), CET1 at 13.2% with the requirement falling to 11.6% (SCB to 3.6%) and a new ~12.8% operating target that frees more capital. A May 7, 2026 Investor Day is set up to lay out the “beyond 10-11%” return target.
  • Rating: Upgrading to Outperform from Hold. At initiation (Q2) we wanted three things before paying up: RoTCE convincingly tracking through 10%, a visible transformation step-down / consent-order milestone, and Banamex de-risking. All three arrived this quarter. With adjusted returns at 9.7% and rising, the transformation two-thirds done, Banamex's exit secured, an accelerating sub/around-book buyback, and a stock at just ~1.04x tangible book versus peers at 1.5-3x, the risk/reward has tilted decisively positive. We upgrade to Outperform; fair value ~$115-125 near-term with a longer runway as the Investor Day frames the destination beyond the waypoint.

Rating Action: Upgrading to Outperform from Hold

We initiated Citigroup at Hold three months ago with a constructive bias and a specific set of upgrade triggers: (1) RoTCE convincingly tracking through 10% with the segment dispersion narrowing; (2) a tangible step-down in transformation/severance spend or a consent-order milestone; or (3) a de-rated entry. The Q3 print delivered the first two in the same quarter — and did so while the franchise set records across the board — so we are upgrading to Outperform.

The case is no longer “the franchise is improving but the returns aren't there.” Adjusted RoTCE of 9.7% is at the doorstep of the 10-11% target, every business set a record third quarter with improved returns, and the two structural overhangs that justified the discount took concrete steps toward resolution: the Banamex exit path is now secured via the Chico Pardo 25% stake (de-risking the last big simplification and freeing ~$37B of RWA at full exit), and the transformation is two-thirds done with controls “in line with peers” and a confirmed 2026 expense step-down. The accretive buyback is accelerating ($5B in the quarter, above guide), and a falling stress capital buffer frees still more.

The stock has crossed above tangible book (~1.04x) for the first time this cycle, but that is the start of the re-rating, not the end — peers trade at 1.5x (BAC/WFC) to 3x (JPMorgan), and Citi's returns are converging toward a level that no longer justifies a below-book multiple. With a May 7 Investor Day teed up to lay out the “beyond 10-11%” destination, we see a multi-quarter re-rating runway. We set fair value at ~$115-125 (roughly 1.2-1.3x tangible book) and would move higher as the medium-term return target is articulated. Upgrading to Outperform; the watch items are a Markets-led Q4 seasonal step-down, the consumer-credit path, and execution on the transformation finish line.

Results vs. Consensus

Strip out the $726M Banamex goodwill impairment — a non-cash, capital-neutral item flagged alongside the stake-sale agreement — and this was a clean, high-quality beat. Adjusted EPS of $2.24 cleared the ~$1.94 Street by ~$0.30; revenue of $22.1B beat by ~2.7% and grew 9%; and the firm delivered positive operating leverage at the consolidated level and at all five businesses for a year-to-date adjusted efficiency improvement of ~360 bps. The reported 8.0% RoTCE is the GAAP figure that absorbs the impairment; the 9.7% adjusted number is the right read on the operating quarter.

MetricQ3 2025 ActualConsensusBeat/MissNotes
Adjusted EPS$2.24~$1.94Beat (+$0.30)GAAP $1.86 incl. $726M Banamex goodwill
Total Revenue$22.1B~$21.5BBeat (+2.7%)+9% YoY; every business record Q3
Net Income (adj.)$4.5Bn/a$3.8B reported
Adjusted RoTCE9.7%n/aAt doorstepYTD 9.2%; reported 8.0%; target 10-11%
Adjusted expenses$13.6Bn/a+3% YoY$14.3B GAAP; efficiency ~360 bps better
Cost of credit$2.5Bn/an/aCard NCLs in range; ACL build
CET1 ratio13.2%n/a110 bps above req.Req. 11.6% from Oct 1; target ~12.8%
TBV / share$95.72n/a+7% YoYStock $99.84 = ~1.04x (above book)

Quality of Print

  • EPS composition: The only material discrete item is the $726M Banamex goodwill impairment (capital-neutral, based on the fair value of 100% of the entity) that bridges reported $1.86 to adjusted $2.24. There was no offsetting one-time gain flattering the adjusted number; the $2.24 is operational. This is the inverse of a low-quality beat.
  • Revenue quality: Nine percent growth with all five businesses at record third-quarter revenue (Services, Markets, Banking, Wealth, USPB) is the broadest print of the year. Markets (+15%) was a record despite low volatility; Banking (+34% total revenue, IB fees +17%) capitalized on the reopening capital-markets window. Only All Other (legacy/corporate) declined.
  • Returns inflection: The segment RoTCEs improved across the board versus Q2 — Banking 9%→12.3%, USPB 11%→14.5%, Services 23%→28.9% — which is exactly the dispersion-narrowing we said the consolidated 10-11% needs. Adjusted firm RoTCE of 9.7% is the highest of Fraser's tenure and within striking distance of target.
  • Credit: Cost of credit was $2.5B, with card NCLs inside the guidance ranges and delinquencies “performing in a very normal fashion.” Reserves were ~$24B (2.7% of funded loans; 8% on cards), built on an 8-quarter weighted-average unemployment of 5.2% (downside scenario ~7%). The one credit watch was a quarter-over-quarter rise in corporate non-accruals, which management attributed to two idiosyncratic downgrades, >2x reserved, with collateral — not a portfolio trend.

Segment Performance

Every operating business set a record third quarter and improved its return — the cleanest possible evidence that the self-help program is broad and compounding, not concentrated in one hot line. The capital-markets-levered businesses (Markets +15%, Banking +34% total revenue) led, while Services kept compounding at a near-29% return and USPB's return jumped into the mid-teens.

SegmentQ3 Revenue YoYNet IncomeRoTCENotable
Services+7% (record)$1.8B28.9%NII +11%; AUCA ~$30T (+13%); cross-border +10%
Markets+15% (record Q3)$1.6B12.3%FICC +12%; equities +24%; prime balances +44%
Banking+34%$0.64B12.3%IB fees +17% (ECM +35%, DCM +19%, M&A +8%)
Wealth+8%$0.37B12.1%Record NNIA $18.6B; BlackRock $80B mandate
U.S. Personal Banking+7% (record $5.3B)$0.86B14.5%Cards +8%; retail bank +30%; Strata Elite launch
All Other (managed)-16%Corporate-other NII down; legacy/Mexico mixed

Services: A Record Quarter at a ~29% Return

The crown jewel set a revenue record on 7% growth and lifted its RoTCE to 28.9% (26.1% YTD). NII rose 11% on higher deposit balances and spreads; total fee revenue grew 6% on the underlying drivers — cross-border transactions +10%, US-dollar clearing volume +5%, assets under custody and administration +13% to nearly $30 trillion. Average loans (+8%, trade-driven) and deposits (+8%, operating-deposit-led) both grew as corporates continued to re-route supply chains. Citi also integrated Citi Token Services with its 24/7 USD clearing network, enabling real-time transfers across 250+ institutions in 40+ markets.

“Services had a record quarter with revenues growing by 7%… AUCA grew 13%, reaching nearly $30 trillion. New client wins and share gains demonstrate the confidence our clients have in our ability to help them navigate a very dynamic global environment.” — Jane Fraser, CEO

Assessment: A near-29% return on a scaled, sticky, capital-light network business is the anchor of the entire Citi re-rating — it is the asset that, properly valued, makes a below-book multiple indefensible. The 24/7-clearing/token-services integration is the right defensive-and-offensive move against the digital-asset disruption debate. Services alone could carry a meaningful sum-of-the-parts argument.

Markets: A Record Third Quarter Despite Low Volatility

Markets revenue rose 15% — a record third quarter even in a low-vol tape — on fixed income +12% (rates & currencies +15% on policy uncertainty) and equities +24% (derivatives, cash volumes, and continued prime momentum with balances up ~44%). RoTCE was 12.3% (13.5% YTD), the sixth straight quarter of positive operating leverage. Average loans rose 24% on financing and spread products.

“Despite low volatility, markets had a record third quarter. Revenues were up 15%… equities grew nicely, with continued progress in prime where balances were up over 40%, complementing our historical strength in derivatives.” — Jane Fraser, CEO

Assessment: The 44% prime-balance growth confirms the “second leg” thesis from Q2 — equities is no longer just a derivatives story. Producing a record in a low-volatility quarter is a structural-share-gain signal rather than a volatility windfall. The caveat management flagged: Q4 seasonally declines, and given the strong Q3 the sequential drop could exceed the usual 15-20% — a known headwind to model into Q4.

Banking: A 34% Revenue Quarter as the Capital-Markets Window Reopens

Banking total revenue jumped 34% on corporate lending (ex-mark-to-market +39%) and investment-banking fees (+17%, with ECM +35% on convertibles, DCM +19% on leveraged finance, and M&A +8% with sponsor share gains). RoTCE reached 12.3% (10.7% YTD) on the seventh consecutive quarter of positive operating leverage, with expenses up just 2%. Management continues to add senior talent in tech, healthcare, and consumer that it expects to bear fruit over the next two-to-three years.

“In banking, increased clarity around tariffs and record equity prices fueled CEO confidence. We capitalized on this with investment banking fees up 17%… we continue to add talent to the team, which will help us deepen or establish relationships that will bear fruit over the next two to three years.” — Jane Fraser, CEO

Assessment: Banking's return finally cleared the firm-average bar (12.3%), and the share-gain trajectory plus the talent build are forward levers. It remains the most cyclical of the five — a reopening capital-markets window is doing real work here — but the operating leverage (revenue +34%, expense +2%) shows the rebuilt platform converts cycle upside efficiently.

Wealth: Record Net New Investment Assets and a BlackRock Mandate

Wealth revenue grew 8% (Citigold and the Private Bank) with record net new investment assets of $18.6B in the quarter (>$52B over the trailing twelve months, ~9% organic), client investment assets +14%, and a new partnership with BlackRock to manage $80B of client assets under an open-architecture strategy. RoTCE was 12.1% (12.5% YTD); the pretax margin was 22% on the sixth straight quarter of positive operating leverage. The retail bank transferred $4B of deposits into Wealth in the quarter, feeding the flywheel.

“Our emphasis on growing investment assets resulted in record net new investment assets of $18.6 billion… we announced a new partnership with BlackRock, where they will manage $80 billion of our clients' assets, fully aligning to an open architecture strategy.” — Jane Fraser, CEO

Assessment: The record net new investment assets are the single best forward indicator in Wealth — flows compound into a recurring fee base. The BlackRock mandate is a credibility signal for the open-architecture pivot. The pretax margin (22%) ticked below Q2's 29% on mix/seasonality, but the multi-year trajectory toward a higher-teens margin remains intact, with the USPB-to-Wealth deposit pipeline a structural tailwind.

U.S. Personal Banking: Record Revenue and a Mid-Teens Return

USPB set a record $5.3B of revenue (+7%) and lifted its RoTCE to 14.5% (12.9% YTD) — a meaningful jump from ~11% at Q2 — on its twelfth consecutive quarter of positive operating leverage. Branded cards grew 8% (loan spreads, +5% interest-earning balances, the well-received Strata Elite launch); retail banking surged 30% on deposit spreads and balances; retail services was roughly flat. Cost of credit was $1.8B (card NCLs, in range).

“USPB had record quarterly revenue of $5.3 billion, reaching 12 straight quarters of positive operating leverage, and delivered an ROTCE of over 14%… we drove momentum in branded cards with the well-received launch of our Citi Strata Elite card.” — Jane Fraser, CEO

Assessment: USPB was the single biggest drag on the consolidated return at Q2 (~11%); a jump to 14.5% is the clearest driver of the firm-level RoTCE moving toward target. The premium-card push (Strata Elite, refreshed American Airlines/Costco) and the 2026 Barclays portfolio addition are revenue levers, and transformation-expense roll-off plus capital optimization remain the margin path toward management's mid-to-high-teens ambition. The laggard is becoming a contributor.

Key Topics & Management Commentary

Overall Management Tone: Confident but pointedly resistant to triumphalism — Fraser repeatedly framed the 10-11% as a “waypoint, not a destination” and, pressed on staff celebrating the stock hitting $100, insisted “no one feels we are declaring victory.” The substance backed the tone: an adjusted 9.7% return, records across all five businesses, a secured Banamex exit path, and a confirmed transformation step-down. The one deliberate hedge was forward-looking caution on a possible market correction (“pockets of valuation fuzziness”) against which management positioned the prime/blue-chip book.

Adjusted Returns Hit 9.7% — the Doorstep of the Target

The number that anchors the upgrade. Adjusted RoTCE reached 9.7% (9.2% YTD), within a hair of the 10-11% 2026 target, with the segment dispersion narrowing as Banking, USPB, and Services all improved returns.

“Excluding the goodwill impairment from the Banamex transaction, our adjusted EPS was $2.24 with an adjusted ROTCE of 9.7%… every business had record third-quarter revenue and improved returns.” — Jane Fraser, CEO

Assessment: A 9.7% adjusted return is the operating proof the Hold rating was waiting for. With the 2026 target at 10-11% and the trajectory plus segment-mix improvement supporting it, the burden of proof has shifted: the question is no longer “can Citi earn its cost of equity” but “how far beyond 10-11% can it go,” which is precisely what the May Investor Day is set up to answer. This is the trigger we required to upgrade.

The Banamex Exit Path Is Now Secured

The single most important structural development. Citi agreed to sell a 25% stake in Banamex to Fernando Chico Pardo at 0.8x book (~$2.3B), securing the path to deconsolidation and ultimately a full exit. His regulatory filing is already in (a 9-12 month Mexican approval process), and the Mexican government has publicly supported the investment. At full exit, ~$37B of RWA is released; the ~$9B cumulative-translation-adjustment hit at deconsolidation is capital-neutral.

“The agreement with Fernando Chico Pardo to purchase a 25% equity stake is a very significant step towards the divestiture of Banamex… we firmly believe that this transaction and the subsequent IPO are going to both maximize value for our shareholders and critically have a high degree of certainty around it.” — Jane Fraser, CEO

Assessment: This de-risks the last big piece of the simplification that has defined the Fraser era. A reputable anchor investor with a 50-year track record adds certainty and credibility ahead of the IPO, and the ~$37B RWA release is a material future capital event. The goodwill impairment and the eventual CTA flow-through are accounting noise around a strategically clean outcome. A genuine overhang moving toward resolution.

Transformation Two-Thirds Done, and the Expense Step-Down Is Confirmed

Over two-thirds of the transformation programs are at or near target state; risk and compliance are “largely at target state” running through sustainability; preventive controls now cover ~$13 trillion of daily payments across 85 countries and >99% of manual institutional payment flows; and Citi is “now in line with peers” on automation and preventive controls. Data-for-regulatory-reporting remediation will take longer but showed “dramatically improved accuracy.” 2025 transformation spend is <$3.5B, confirmed to come down in 2026.

“Over two-thirds of our programs are at or mostly at Citi's target state… we're now in line with peers in terms of level of automation and preventative controls… we're looking forward to the transformation expense coming down next year.” — Jane Fraser, CEO

Assessment: The expense step-down is the mechanical bridge from a ~62-64% efficiency ratio to the sub-60% Mason targets exiting 2026, and from 9.7% toward a double-digit-plus RoTCE. Quantifying the 2025 spend (<$3.5B) and confirming the 2026 decline is the “visible step-down” trigger we set at initiation. Reg-data remains the long pole, but the controls progress and the peer-parity claim are meaningful de-risking.

Capital: $5B Buyback Above Guide, Crossing Tangible Book, the 12.8% Target

Citi returned >$6B to common ($5B of buybacks, $1B above guide; $8.75B YTD of the $20B program). CET1 ended at 13.2% (110 bps above the 12.1% requirement); from October 1 the requirement falls to 11.6% on the SCB cut to 3.6%, and management set a new operating target of ~12.8% CET1 (a 3.8% two-year-average SCB plus a 100 bps buffer), freeing capital toward buybacks.

“We're still adding around one times tangible book value. I think there's more upside to the stock, and so we want to strike that right balance between return on and return of [capital].” — Mark Mason, CFO

Assessment: Buying back $5B at ~1x tangible book remains accretive, and a falling required CET1 (toward 12.8% from 13.2%) frees a meaningful amount of additional capital to deploy. The accelerating pace and the explicit “more upside to the stock” signal management conviction. This is the most certain leg of the Outperform case and the floor under the downside.

Tokenized Deposits over Stablecoins — Fraser's Payments Vision

Pressed on stablecoin adoption, Fraser reframed the debate toward tokenized deposits as the better institutional solution, arguing the over-focus on stablecoins misses where Citi's payments leadership actually lands. Citi linked Citi Token Services to its 24/7 USD clearing network (250+ banks, 40+ markets) and will provide on/off ramps, custody, and cash-management to stablecoin providers, while considering its own “TrueCity” stablecoin.

“There's an over-focus on stablecoin at the moment, whereas as a major payments player, most of this is going to get solved by the tokenized deposit capabilities… the gating factor is our clients' treasury departments being ready for an always-on environment.” — Jane Fraser, CEO

Assessment: The right strategic read — tokenized deposits keep the value inside Citi's regulated rails and avoid the on/off-ramp, tax, and AML friction of stablecoins, while the 24/7-clearing integration extends the network advantage. Over a multi-year horizon digital assets remain the variable to watch in Services, but Citi is positioning as a beneficiary. Not a near-term thesis factor; a long-term moat reinforcement.

The May 7 Investor Day — the “Beyond 10-11%” Reveal

Management set a May 7, 2026 Investor Day to lay out the longer-term return target and the per-business path beyond the 10-11% waypoint — timed to follow expected first-quarter clarity on GSIB, Basel III endgame, CCAR, and the SCB-averaging rule.

“In terms of what will come next, we very much look forward to sharing that with you at our next Investor Day, which will be on May 7. There is still so much upside left for us to capture.” — Jane Fraser, CEO

Assessment: A clear, dateable catalyst. With the operating returns at the doorstep of 10-11% and the regulatory picture expected to clarify in Q1, the Investor Day is the venue to put a number on the “destination” and potentially reset the capital target lower — both re-rating catalysts. It anchors the Outperform thesis with a specific event to underwrite toward.

Guidance & Outlook

MetricFY2025 Guide (Q3 update)PriorDirectionNotes
Total revenue>$84B~$84BRaised againConfident to exceed on 7% YTD growth
NII ex-marketsup ~5.5%~4%RaisedStronger performance + FX
Expensesabove prior ~$53.4B~$53.4BHigher (FX + rev)Efficiency ratio ~64% ex-impairment held
Markets Q4down 15-20%+ QoQn/aSeasonalCould exceed range on strong Q3
Credit (NCL ranges)Unchanged3.5-4.0% card / 5.75-6.25% RSMaintainedDelinquencies normal
BuybackContinue under $20B program≥$4B Q3 (did $5B)Ahead$8.75B YTD; no precise guide
2026 RoTCE target10-11%10-11%Reaffirmed“Waypoint, not destination”; sub-60% efficiency exit

The FY revenue guide moved up again (now “exceed $84B”) with NII ex-markets raised to ~+5.5%; expenses come in a touch higher on FX and the revenue overshoot, but the efficiency ratio (~64% ex-impairment) was held. The forward model hinges on 2026: continued top-line momentum plus the transformation/severance/stranded-cost roll-off that bridges to a sub-60% efficiency ratio and the 10-11% RoTCE. Management explicitly framed even that as a waypoint, with the destination to be quantified in May.

Implied earnings power: A >$84B revenue year against ~$54B of (FX-inflated) expense and a stable cost of credit puts FY2025 adjusted EPS around ~$8.00-8.40 and supports a ~9.2% adjusted RoTCE — the bridge to the 2026 target. We model FY2026 EPS approaching ~$9.50-10.50 as the transformation step-down lands, the share count shrinks on accretive buybacks below/around book, and the segment mix continues to improve toward a 10-11%+ RoTCE.

Guidance posture: Confident and serially raised through the year, with the one honest hedge a Markets Q4 seasonal decline that “could exceed” the usual 15-20%. The withheld quarterly buyback guidance and the deferral of the “destination” target to May are the two acknowledged information gaps.

Analyst Q&A Highlights

The Consent Order and Regulatory-Data Progress

The opening question pressed for a substantive update on the consent-order work, especially the regulatory-data remediation. Management detailed broad controls progress and peer-parity on automation, while acknowledging reg-data “will take more time.”

Q: “Can you give us an update on your actions with the consent order as it relates to risk, compliance, controls, and reg data? And elaborate on the reg-data part…”
— Mike Mayo, Wells Fargo Securities

A: “Over two-thirds of our programs are at or mostly at Citi's target state… we now have preventive controls for large and anomalous payments in 85 countries… we're now in line with peers… data for regulatory reporting is going to take more time, but we've made significant progress… dramatically improved accuracy.”
— Jane Fraser, CEO

Assessment: The most decision-relevant disclosure for the rating. Peer-parity on controls and two-thirds-at-target-state, plus a quantified <$3.5B 2025 spend confirmed to fall in 2026, is the visible transformation step-down we required to upgrade. Reg-data remains the long pole, but the trajectory is now concrete rather than aspirational.

The Banamex Transaction Timing and Value

A recurring line of questioning sought clarity on how the Chico Pardo stake sale interacts with the IPO timeline and the ultimate value realization.

Q: “How are you thinking about the timing between the offers you've received versus the IPO timing… and is there a timeframe in mind for ultimate value determination?”
— Betsy Graseck, Morgan Stanley

A: “The 25% stake is a very significant step in our path towards deconsolidation and ultimately a full exit… the Mexican president and her government have been publicly very supportive… his regulatory approval filing was put in this week… that typically takes nine to twelve months.”
— Jane Fraser, CEO

Assessment: The exchange surfaced the certainty the deal adds — a credible anchor investor, government support, and a filed regulatory clock — which is exactly the Banamex de-risking the Hold thesis wanted. The ultimate value still depends on the IPO, but the path is now secured rather than open-ended.

The 2026 Efficiency Path and the Sub-60% Exit

Asked whether expenses could fall in 2026 even with strong revenue, and whether a sub-60% efficiency exit is realistic, Mason walked the levers while stressing the need to keep investing.

Q: “Is it fair that you see a path for directionally down expenses next year even if revenues are strong? And do you still see the potential to exit next year at an efficiency ratio below 60?”
— John McDonald, Truist Securities

A: “I lead with the 10% to 11%… transformation expense coming down, legacy/stranded costs continuing to come down, productivity… a lower, more normalized severance… but it's also going to require investments… I'm targeting the less than 60 as I come out of 2026.”
— Mark Mason, CFO

Assessment: The sub-60% efficiency exit and the 10-11% RoTCE are two framings of the same operating-leverage story, and the levers (transformation roll-off, stranded costs, severance normalization, productivity) are credible and largely self-help. The honest caveat — reinvestment to sustain top-line momentum — is the right discipline, not a hedge. Supports the forward EPS bridge.

The Capital Target and the Buyback Pace

An analyst pressed on whether the stepped-up buyback pace continues until CET1 reaches the 12.8% target.

Q: “On the capital target of 12.8% and stepped-up buybacks this quarter — is this a pace we should expect until you get to 12.8%? How quickly do you get there?”
— Jim Mitchell, Seaport Global

A: “I'm smiling because last quarter I said we weren't going to give guidance on a quarterly basis… but we have a $20 billion buyback program… you'll see 13.2% come down towards [12.8%] over the next couple of quarters… we're still adding around one times tangible book value. I think there's more upside to the stock.”
— Mark Mason, CFO

Assessment: The CFO signaling CET1 drifting from 13.2% toward 12.8% “over the next couple of quarters” implies a sustained, elevated buyback — accretive at ~1x book and a direct per-share-value and RoTCE lever. The “more upside to the stock” comment is an unusually direct expression of management conviction. Reinforces the Outperform.

Consumer and Corporate Credit — the Non-Accrual Uptick

Questioned on a quarter-over-quarter rise in corporate non-accruals and any consumer-credit red flags, management attributed the NAL move to two idiosyncratic names and described the consumer book as discerning and well-reserved.

Q: “When we think about the consumer cards book… any red or yellow flag? And… a pretty decent jump in corporate non-accruals quarter over quarter — was that a one-off?”
— Ebrahim Poonawala, Bank of America

A: “The quarter-over-quarter increase is really driven by two idiosyncratic downgrades… NAL reserve coverage remains adequate at over two times… On consumer, the losses are inside of the ranges… delinquency trends are performing in a very normal fashion… we're running our operations in a recession-ready mode.”
— Mark Mason, CFO

Assessment: A satisfactory answer — the corporate NAL uptick is name-specific, >2x reserved, not a portfolio signal, and the 85%-prime consumer book continues to perform in line with normal seasonality. The “recession-ready” posture and 5.2% weighted-average-unemployment reserve assumption (downside ~7%) leave Citi well-positioned for the market correction Fraser flagged. Credit is not the watch item it might be at a lower-quality lender.

The NDFI / MBFI Exposure

With industry attention on bank lending to non-depository financial institutions, an analyst asked Citi to characterize its ~$104B book.

Q: “There's been a lot of discussion… about loans to non-depository financial institutions… about $104 billion here — can you give us some color into the different lines you lend into and how comfortable you are with this credit?”
— Gerard Cassidy, RBC Capital Markets

A: “This MBFI disclosure… consists of a very broad set of exposures… primarily made up of securitization exposures with diversified collateral pools… predominantly investment grade… ample subordination… transparency at the loan-by-loan level… very selective from a risk perspective.”
— Mark Mason, CFO

Assessment: A reassuring, granular answer to the market's topical private-credit worry — the book is securitization-heavy, investment-grade, well-subordinated, and monitored loan-by-loan, not a concentrated direct-lending bet. Consistent with the blue-chip, prime-skewed risk posture that is one of Citi's underappreciated strengths. Not a hidden risk on current disclosure.

What They're NOT Saying

  1. The 2027+ RoTCE “destination” target. The repeated “waypoint” framing all but promises a higher number, but management deferred it explicitly to the May 7 Investor Day — leaving the size of the ultimate return profile (and the fair multiple) to inference until then.
  2. The end-state of the ~$3.5B transformation spend. Asked directly whether it goes away or morphs into BAU, Mason smiled and deferred to Investor Day — quantifying only that it falls in 2026. The single most important multi-year cost line still lacks a terminal number.
  3. Quarterly buyback guidance — still withheld. Mason again declined to guide the quarterly pace (twice noting the prior-quarter withdrawal), pointing only to the $20B program and a CET1 drift toward 12.8%. The per-share-accretion cadence remains a model input rather than a disclosed figure.
  4. The ultimate Banamex valuation and loss-on-sale. The 25% stake priced at 0.8x book; the eventual IPO valuation, the cumulative gain/loss on sale, and the timing to full exit (beyond a 9-12 month regulatory clock) are all still open.
  5. Whether the 100 bps management buffer comes down. Management “looks at it all the time” but would not commit to lowering it despite a more stable, predictable earnings stream and a falling SCB — a potential further capital-release lever held in reserve until the regulatory picture clarifies.

Market Reaction

  • Pre-print setup: C closed at $96.10 on October 13, up 36.5% YTD and 45.6% over the trailing twelve months — a powerful re-rating run, though the stock had cooled 3.4% over the trailing 30 days into the print, with a 52-week closing high of $103.49 overhead.
  • Reaction-day move: The stock gapped slightly lower (-0.8% to $95.37), then rallied to an intraday high of $101.22 and closed at $99.84 — up 3.9% ($3.74) on the session — while the S&P 500 fell 0.2%. A ~4-point relative outperformance, and a close above tangible book ($95.72 TBVPS).
  • Volume: 33.2M shares versus a 13.2M 30-day average — 2.5x normal, confirming genuine institutional repositioning into the print.
  • Read-through: The market rewarded the adjusted beat, the records across all five businesses, the Banamex de-risking, and the above-guide buyback — pushing the stock to ~1.04x tangible book, a premium to book for the first time this cycle. Staff reportedly celebrated the $100 milestone; management pushed back on any sense of victory.

Net read: a deserved up-move on a high-quality, broad-based beat and two structural de-riskings (Banamex, transformation). Crossing above tangible book is a psychological and analytical milestone — it marks the moment the market stopped pricing Citi as a value trap. But at ~1.04x TBV versus peers at 1.5-3x, with returns converging on 10-11% and a destination target coming in May, this is the beginning of the re-rating, not its culmination. The setup supports our upgrade.

Street Perspective

Debate: Is the re-rating to ~1x tangible book the end, or just the start?

Bull view: Just the start. Crossing tangible book on a 9.7% return is the inflection; as returns push through 10-11% and the May Investor Day quantifies the destination, the multiple should expand toward peers (1.5-3x). Citi at 1.04x TBV with improving returns is still the cheapest big bank by a wide margin.

Bear view: The easy re-rating — from distressed lows to tangible book — is done, and the stock has nearly doubled off its lows. A 9.7% return barely earns the cost of equity; paying a premium to book requires believing in a transformation finish and a 2026 target that has slipped before.

Our take: The bull has the better of it now that the triggers have fired. The difference versus our Q2 Hold is that the returns are no longer a forecast — 9.7% is printed, the segment mix is improving, and the overhangs are de-risking. We side with continued re-rating toward ~1.2-1.3x TBV, with the Investor Day the catalyst to extend it.

Debate: Can 9.7% adjusted become a durable 10-11%+ — through the Mexico and Markets noise?

Bull view: Yes — the 9.7% already absorbs heavy transformation spend that falls in 2026, USPB and Banking returns are still climbing, Services compounds at ~29%, and the buyback shrinks the equity base. The Mexico goodwill/CTA items are one-time accounting; the underlying earnings power is higher than the GAAP optics.

Bear view: Q3 leaned on a record Markets quarter and a reopened banking window that won't repeat every quarter (Q4 Markets is guided down 15-20%+), and the consolidated number still flatters on adjustments. A clean, sustained double-digit return through a softer capital-markets tape is unproven.

Our take: We think 10-11% in 2026 is reachable and durable because the bridge is mostly self-help (expense roll-off, capital optimization, segment-mix) rather than cycle-dependent. The Markets seasonality is real but known; the trajectory of the non-cyclical lines (Services, USPB, Wealth) is what underwrites the durability. Credible.

Debate: Is the ~$104B NDFI / private-credit book a hidden risk?

Bull view: No — the MBFI disclosure is broad and securitization-heavy, predominantly investment grade, well-subordinated, and monitored loan-by-loan. Citi's blue-chip corporate book and 85%-prime consumer skew are exactly the risk posture you want late in a cycle.

Bear view: Industry NDFI exposure has more than doubled in five years; rapid growth in opaque private-credit-adjacent lending is precisely where the next cycle's surprises tend to surface, and disclosure is coarse.

Our take: On the granular answer management gave, this is not a near-term concern for Citi specifically — the book is structured, IG, and diversified, with the idiosyncratic corporate-NAL uptick already named and reserved. We flag it as a sector-wide monitorable, not a Citi-specific thesis risk.

Model Implications

ItemPrior FramingOur ViewReason
FY2025 revenue~$84B>$84BGuide raised; 7% YTD growth
FY2025 adjusted EPS~$7.10-7.40~$8.00-8.40Strong Q3; adjusted basis; accretive buyback
FY2025 adjusted RoTCE~9%~9.2%YTD adjusted; on bridge to 10-11%
FY2026 EPS~$8.50-9.00~$9.50-10.50Transformation step-down, lower share count, mix
2026 RoTCE~10-11%10-11% (bias up)Segment returns improving; sub-60% efficiency exit
Buyback / capital$20B program$20B; CET1→12.8%$5B Q3 above guide; SCB relief frees more
BanamexIPO 2025/2625% stake closes; ~$37B RWA release at exitChico Pardo agreement; 9-12 mo approval

Valuation framing: At the $99.84 reaction-day close, Citi trades at ~1.04x tangible book ($95.72 TBVPS) and ~12x our FY2025 adjusted EPS — still the cheapest large-cap US bank (JPMorgan ~3x TBV; BAC/WFC ~1.5-1.7x). With adjusted returns at 9.7% and converging on 10-11%, a below/at-book multiple is no longer defensible. We set fair value at ~$115-125 (roughly 1.2-1.3x tangible book) on partial multiple convergence as returns clear the cost of equity and the overhangs resolve — with upside to ~$135-145 if the May Investor Day frames a credible “beyond 11%” destination and the capital target steps lower. The accretive buyback below/around book continues to compound per-share value while we wait.

Thesis Scorecard — Post-Earnings

Thesis PointStatusNotes
Bull #1: Returns inflecting toward 10-11%ConfirmedAdjusted RoTCE 9.7%; every segment return up QoQ
Bull #2: Transformation step-down / consent-order milestoneConfirmedTwo-thirds at target; controls peer-parity; spend down 2026
Bull #3: Banamex de-riskingConfirmedChico Pardo 25% stake; ~$37B RWA release at exit
Bull #4: Capital return below/around book is accretiveConfirmed$5B Q3 (above guide); CET1→12.8%; SCB falling
Bull #5: Services crown jewel + capital-markets strengthConfirmedServices 28.9% RoTCE; all 5 businesses record Q3
Bear #1: Returns still only ~cost of equityImproving9.7% adjusted; durability through a softer tape unproven
Bear #2: Reg-data remediation the long poleActive“Will take more time”; accuracy improving
Bear #3: Markets Q4 seasonal step-downWatchGuided down 15-20%+ QoQ; known headwind
Bear #4: Possible market correction / macroWatchFraser flags “valuation fuzziness”; prime/blue-chip book

Overall: The thesis stepped up decisively. The three upgrade triggers we set at initiation — a returns inflection through ~10%, a visible transformation step-down, and Banamex de-risking — all printed in the same quarter, and the franchise set records across all five businesses while doing it. The remaining concerns (returns durability through a softer capital-markets tape, reg-data, the Markets Q4 seasonality, a possible market correction) are watch items, not thesis breaks, and Citi enters them with a prime, blue-chip, well-reserved book.

Action: Upgrading to Outperform from Hold. Adjusted returns at the doorstep of target, two structural overhangs de-risking, an accelerating accretive buyback, a stock that just crossed tangible book at a wide discount to peers, and a dateable May 7 Investor Day catalyst together tilt the risk/reward decisively positive. Fair value ~$115-125 near-term, with upside to ~$135-145 as the destination beyond the waypoint is framed. We would revert to Hold only on a returns stall, a Banamex setback, or a consumer-credit break; none is in view. Outperform.